期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cell Stem Cell LetPub Score 9.7
50 ratings
Rate
Reputation 10.0 Influence 9.6 Speed 9.1 | ||||||||||||||||||||||||
期刊簡稱 | CELL STEM CELL | ||||||||||||||||||||||||
ISSN | 1934-5909 | ||||||||||||||||||||||||
E-ISSN | 1875-9777 | ||||||||||||||||||||||||
h-index | 212 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.cell.com/cell-stem-cell/home | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CELL-STEM-CELL | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Cell Press | ||||||||||||||||||||||||
主題領域 | 生物 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2007 | ||||||||||||||||||||||||
每年文章數 | 97每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 82.67% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1934-5909%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 20% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Cell Stem Cell] 的評論 | 撰寫評論 |
作者: 回风念雁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-17 14:03:12 評論於 How are you, buddy?(0) 讚! | 回风念雁 |
作者: 風見书娟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-05 16:57:39 評論於 Submitted on February 8th, reviewed on the 11th, currently under review. Hopefully will have news soon, feeling anxious(0) 讚! | 風見书娟 |
作者: 平原鹏举 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-02 19:23:42 評論於 Research Focus: Stem Cells; Sharing of iPS Experience: Submitted on January 29th, received rejection email on January 31st, extremely fast. Feedback was that the article lacked originality(0) 讚! | 平原鹏举 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:45:09 評論於 If the method is described for the first time, it needs to be detailed, as a thorough description of the method demonstrates the rigor and thoughtfulness of the research work; however, if the method has already been described in a previously published paper, a brief description with a reference is sufficient(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:44:53 評論於 For example, the experimental techniques of PCR, Western blot, and the instructions for using some instruments(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 19:51:15 評論於 What is the standard operating procedure for laboratory use?(0) 讚! | 龙鳞孝礼 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:33:46 評論於 When should the methods section be described in detail and when can it be abbreviated?(0) 讚! | 上清雨真 |
作者: 法慧佳文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-17 21:47:57 評論於 Submitted an article to the field of blood, rejected a week later without review, the editor's feedback was that our research was more suitable for a journal in the field of blood, and may not be attractive enough to scholars in the field of stem cells. The rejection letter indicates that the editor carefully read our article and has high standards, hoping for future work to be submitted to this journal(0) 讚! | 法慧佳文 |
作者: 邻家飞跃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-09 13:48:24 評論於 Review Speed: 1.0 | Acceptance Rate: 5.0 Sharing Experience: Has it been so long since someone commented? This journal is now a top journal in the field of stem cells. Very difficult to publish in(0) 讚! | 邻家飞跃 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 17:19:14 評論於 Who can predict how many points there will be next year?(0) 讚! | 凌霄高洁 |
作者: 碧桃春玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-23 12:42:15 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 25.0 Share of Experience: Real research journals prioritize quality(0) 讚! | 碧桃春玲 |
作者: Anonymous 領域: 生命科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-08-23 10:16:05 評論於 The real scientific journal, quality first.(2) 讚! | Anonymous |
作者: 华清如仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-17 19:32:10 評論於 It's nice to relax under the shade of a big tree, aim diligently(0) 讚! | 华清如仪 |
作者: 匿名 領域: 细胞生物学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2010-12-01 11:43:00 評論於 This is the famous "Cell" journal from Cell Publishing that publishes innovative biological research studies. If you end up being rejected from Cell, there are other options in the Cell Publishing family, such as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chem Biology, Cell Metabolism and the Seed Journal. (1) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-11-04 23:44:53 評論於 It was easier to publish when the magazine was just launched, all you needed was some basic ideas. Now it's more difficult as higher level of innovation is required(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-01-06 17:15:26 評論於 The top article on stem cells, I want to publish it, but it's difficult(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2009-09-30 16:05:18 評論於 Under the Cell flag, although it was just launched, IF is already ranked as number one in the field of stem cells. Therefore, top-tier institutions might consider submitting to this journal. High originality is required, and strong systematicity is also desired. Many articles have been published in this journal in the past two years domestically(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us